Esperion Therapeutics's publication in Cell Metabolism
SMC announces that Esperion Therapeutics (MI, USA) has published the results of a study using STAM™ mouse model in Cell Metabolism.
Title: “Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia”
For detailed information, see the below URL.
Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia – PubMed (nih.gov)